Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
benzydamine (benzydamine hydrochloride), cetylpyridinium chloride
KRKA d.d.
R02AA20
benzydamine (benzydamine hydrochloride), cetylpyridinium chloride
3mg+ 1mg
lozenges
(8/1x8/), (16/2x8/), (24/3x8/), (32/4x8/) and (40/5x8/) in blister
OTC
Registered
2018-08-31
1.3.1 Benzydamine hydrochloride + Cetylpyridinium chloride SPC, Labeling and Package Leaflet AM L1HCTPYKLJ,I15I NO ME)J;I1LJ,I1HCKOMY NPI1MEHEHJ;110 J1EKAPCTBEHHORO [JPEF1APATA C ® ENTOJ]ETE TOTAJ]JLHMOH H 6Y3HHA S ® EPTOLETE TOTAL LEMON AND ELDERFLOWER TOPROBOE HALLLUCHOBAHIICNPCNAPANL: CenToneTe li TOTaJJmfMOH H 6Y3HHa MelK.ll.YHapo~Hoe NCNATCHTOBAHHOCNA:MAHUC: 6eH3HtlaMHH H lJ,eTHJlnHpHLl.HHHlI XnOpHLI. JICKAPCTBCHHAH 4>0PMA: JleLl.eHlJ,bJ ;IRHUVL ~ I ••• EOCTAS EX PER _II_ _dL-1_ _j-(?,_ _M.MItf;_ , P P L I [ , II T .'. : _~-#'/ _/::r._ _i)_d' _/0_ _A_ _"mUGlloe_ _Gel/wcmGo:_ J JleLl.eHeu COtleplI(HT 6eH3HtlaMHHa rHtlPOXJlOpHLl.a 3 Mr H ueTHnnl1pHLl.I1HHll xJlopl1,na J Mr. MacJlo nepe4HoH MllTbl, neBOMeHTOJl, cyKPaJJo3a (E955), JlHMOHHall KHCJlOTa (E330), H30MaJJbT (E953), U~iTpyCOBbJj;j apoMaTH3aTop (co,nep)KalllI1H 6YTI1Jll1pOBaHHbJH rYf,npOKCHaHH30Jl (E320»). apoMaTH3aTop 6y3HHbJ (co,nepllAPMAKOTEPANEBTLI'ICCKAH RPYNNA: npenapaTbJ ,nm ne'leHHSl 3a6oneBaHHH ropna, aHTl1CenTHK~1. KOJL A TX: R02AA20. $APMAKOJLORLL'ICCI.:NC CBOHCTBA _(/)AP .._ _LLM(.()()IIF/{I/1L1I_ _K(I_ I SmPCPIL 105029 8 121.12.2017 - Updated: 02.07.2018 Page 1 of6 1.3.1 Benzydamine hydrochloride + Cetylpyridinium chloride SPC, Labeling and Package Leaflet AM MOJleKYJla C HeCTepOI1,llHOH XI1MI1'leCKOH CTPYKTYPOM C npOTI1BOBOCflanHTeJlbHblMH H ooe36omIBatOll.(HMH cBoi1CTBaM~1. C'lI1TaeTCl1, 'ITO Mexaml3M ,lleHCTBl1ji OflOCpe,llOBaH I1Hrl16HpOBaHHeM CHHTe3a flpOCTarnaH,ll~IHOB, a TaK)Ke YMeHbweHI1eM MeCTHblX npl13HaKOB BocnaneHl1.S1 (TaKI1X KaK 60Jlb, nOKpacHeHI1e, OTeK, )Kap 11 Hapyw Read the complete document
1.3.1 Benzydamine hydrochloride + Cetylpyridinium chloride SPC, Labeling and Package Leaflet AM SmPCPIL150918_1 28.07.2020 – Updated: 28.07.2020 Page 1 of 6 1. NAME OF THE MEDICINAL PRODUCT Septolete ® total lemon and elderflower 3 mg/1 mg lozenges 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each lozenge contains 3 mg benzydamine hydrochloride and 1 mg cetylpyridinium chloride. Excipient with known effect: - isomalt (E953): 2448.3 mg/lozenge - butylated hydroxyanisole (E320): 0.0004 mg/lozenge - sodium benzoate (E211): up to 0.00075 mg/lozenge - propylene glycol (E1520): 4.8 mg/lozenge For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lozenge Round lozenges with bevelled edges and rough surface from pale green to green colour. Allowed white patches, uneven colouring, the presence of air bubbles in the “hard candy” mass and small jagged edges. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sewptolete total lemon and elderflower is indicated in adults, adolescents and children over 6 years of age for anti-inflammatory, analgesic and antiseptic treatment of irritations in the throat, mouth and gums, in gingivitis, pharyngitis and laryngitis and before and after tooth extractions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology ADULTS: The recommended dosage is 3 4 lozenges a day. The lozenge should be slowly dissolved in the mouth every 3 to 6 hours. ELDERLY PATIENTS: The recommended dose is the same as for adults. _Paediatric population_ ADOLESCENTS OVER 12 YEARS OF AGE: The recommended dosage is 3 4 lozenges a day. The lozenge should be slowly dissolved in the mouth every 3 to 6 hours. CHILDREN AGED FROM 6 TO 12 YEARS OF AGE: The recommended dosage is 3 lozenges a day. The lozenge should be slowly dissolved in the mouth every 3 to 6 hours. CHILDREN LESS THAN 6 YEARS OF AGE: Sewptolete total lemon and elderflower is contraindicated in CONFIDENTIAL Septolete total lemon and elder flower lozenges VOL: 1; P: 19 / 89 1.3.1 Benzydamine hydrochloride + Cetylpyridinium chlorid Read the complete document